A systematic review on the role of MSC-derived exosomal miRNAs in the treatment of heart failure
Botello-Flores, Yesica Abril, Martha Yocupicio-Monroy, Norma Balderrábano-Saucedo, and Alejandra Contreras-Ramos. 2022. “A Systematic Review on the Role of MSC-Derived Exosomal MiRNAs in the Treatment of Heart Failure.” Molecular Biology Reports, April. https://doi.org/10.1007/s11033-022-07385-2.
Background This systematic review summarizes results of studies that evaluated the expression of microRNAs (miRs) in pre-diabetes or type 2 diabetes. Methods The information was obtained in PubMed, EMBL-EBI, Wanfang, Trip Database, Lilacs, CINAHL and Google. A qualitative synthesis of the results was performed and miRs frequency was graphically. From 1880 we identified studies, only 53 fulfilled the inclusion criteria. The 53 studies analyzed miRs in T2D; and of them, thirteen also described data in pre-diabetes. Results In diabetics, 122 miRs were reported and 35 miRs for pre-diabetics. However, we identified that 5 miRs (-122-5p, 144-3p, 210, 375, -126b) were reported more often in diabetics, and 4 (144-3p, -192, 29a and -30d) in pre-diabetics. Conclusions Circulating miRs could be used as biomarkers of type 2 diabetes. However, it is necessary to validate these microRNAs in prospective and multi-center studies, where different population subgroups, considering the age, gender, and risk factors.